Dr. Sarah W. Gordon, DO
Claim this profileVirginia Commonwealth University/Massey Cancer Center
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
26 reported clinical trials
54 drugs studied
About Sarah W. Gordon, DO
Education:
- Earned a DO (Doctor of Osteopathic Medicine) degree from an accredited institution.
Experience:
- Specializes in Gynecologic Oncology at Virginia Commonwealth University (VCU).
- Provides comprehensive surgical education for residents, with expertise in open and robotic surgeries.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Sarah W. Gordon, DO is currently running
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about Sarah W. Gordon, DO
Clinical Trial Related9 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Sarah W. Gordon, DO has experience with
- Pembrolizumab
- Carboplatin
- Nivolumab
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
- Cisplatin
Breakdown of trials Sarah W. Gordon, DO has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sarah W. Gordon, DO specialize in?
Sarah W. Gordon, DO focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Sarah W. Gordon, DO currently recruiting for clinical trials?
Yes, Sarah W. Gordon, DO is currently recruiting for 5 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Sarah W. Gordon, DO has studied deeply?
Yes, Sarah W. Gordon, DO has studied treatments such as Pembrolizumab, Carboplatin, Nivolumab.
What is the best way to schedule an appointment with Sarah W. Gordon, DO?
Apply for one of the trials that Sarah W. Gordon, DO is conducting.
What is the office address of Sarah W. Gordon, DO?
The office of Sarah W. Gordon, DO is located at: Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University/Massey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.